姓名:梁德胜
职称:副教授
邮箱:lds0823@ncu.edu.cn
籍贯:湖北黄石
导师类型:硕士生导师
主讲课程:药剂学、药学导论
个人主页:
纳米载体给药系统;肿瘤纳米疫苗;蛋白多肽药物缓控释微球
2005.9~2009.7:中国农业大学,应用化学专业,理学学士
2009.9~2012.7:中国科学院大学,药物设计专业,理学硕士
2012.9~2015.7:北京大学医学部,药剂学专业,理学博士
2019.5~2023. 9:美国密歇根大学药学院,博士后
2015.8~至今:南昌大学药学院药剂教研室,讲师、副教授
教育部博士硕士学位论文评审专家;
Colloids Surface B、J Drug Target、Int J Nanomed、J Control Release等SCI学术期刊论文审稿专家
2018年荣获南昌大学本科生优秀毕业设计论文指导老师;
2021年荣获第七届中国互联网+创新创业大赛国际赛道铜奖指导老师;
一、 主要科研成果
主持国家自然科学基金和省级自然科学青年基金各1项,参与多项国家和省部级科研项目。累计发表SCI期刊学术论文20余篇,其中以第一作者和通讯作者发表SCI收录论文16篇。参编专业教材2部、参与建设江西省虚拟仿真实验教学项目1项、指导研究生荣获第七届中国互联网+创新创业大赛国际赛道铜奖1项以及江西省药学学科联盟“卓越杯”科研创新大赛论文展评二等奖1项。
1、 主持科研课题:
[1] 梁德胜. 肿瘤细胞与炎性微环境双靶向响应性纳米载药系统的构建及其用于肿瘤联合治疗的研究, 国家自然科学基金, 40.8万, 2018.1-2021.12, No. 81760640.
[2] 梁德胜. 靶向肿瘤干细胞智能响应性纳米前药自传递系统的构建及其抗肿瘤活性研究,江西省自然科学青年基金, 6.0万, 2019.1-2022.12, No. 20192BAB215062.
[3] 梁德胜. 靶向智能响应性盐霉素/环巴胺前药纳米粒制备及其抗乳腺癌干细胞活性研究,南昌大学医学部青年教师科研培育基金, 5.0万, 2018.06-2021.06, No. PY201809.
2、发表代表性论文:
[1] Liang DS, Frank S, Schwendeman SP*. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release, Drug Deliv Transl Res. 2023, accepted.
[2] Liang DS, You WP, Zhu FF, Wang JH, Guo F, Xu JJ, Liu XL, Zhong HJ*. Targeted delivery of pexidartinib to tumor-associated macrophages via legumain-sensitive dual-coating nanoparticles for cancer immunotherapy, Colloids Surf. B 2023,226:113283.
[3] Liu X(#), Guo F(#), Liang DS(#) (共同一作), Li ZL, Cao YT, Chen MQ, Xu JJ, Liu XL, Zhong HJ*. Development and evaluation of finasteride niosomes targeting to hair follicles for the management of androgenic alopecia, J Drug Deliv. Sci. Tec. 2023,86:104725.
[4] Liang DS, Wen ZJ, Wang JH, Zhu FF, Guo F, Zhou JL, Xu JJ, Zhong HJ*. Legumain protease-sheddable PEGylated, tuftsin-modified nanoparticles for selective targeting to tumour-associated macrophages, J Drug Target 2022,30(1):82-93.
[5] Peng H, Wang JH, Guo F, Zhu FF, Wen ZJ, Zhong HJ, Liang DS*. Legumain protease-activated tuftsin-functionalized nanoparticles for dual-targeting TAMs and cancer chemotherapy, Colloids Surf. B 2021,197:111442.
[6] Guo F, Ouyang T, Peng TX, Zhang XY, Xie BG, Yang XL, Liang DS* (共同通讯), Zhong HJ*. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides, Biomater Sci 2019,7:1493-1506.
[7] Peng TX (#), Guo F(#), Liang DS(#) (共同一作), Gao Y, Zhang XY, Qiu SP, Liu J, Zhong HJ*. Improved gastrointestinal stability of solid lipid nanoparticles using comb-shaped amphiphilic inulin derivatives, Pharmazie 2019, 74: 47–53.
[8] Liang DS, Liu J, Peng TX, Peng H, Guo F*, Zhong HJ*. Vitamin E-based redox sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy, Colloids Surf. B 2018,172:506-516.
[9] Qiu SP(#), Liang DS(#)(共同一作), Guo F(#), Deng TT, Peng TX, Gao Y, Zhang XY, Zhong HJ*. Solid lipid nanoparticles modified with amphipathic chitosan derivatives for improved stability in the gastrointestinal tract, J Drug Deliv. Sci. Tec. 2018,48:288-299.
[10] Liang DS, Zhang WJ, Wang AT, Su HT, Zhong HJ, Qi XR*. Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles, Biomaterials, 2017, 137: 23-36
[11] Liang DS, Su HT, Liu YJ, Wang AT, Qi XR*. Tumor-specific penetrating peptides-functionalized hyaluronic acid-D-a-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers, Biomaterials, 2015, 71: 11-23.
[12] Liang DS, Wang AT, Yang ZZ, Liu YJ, Qi XR*. Enhance cancer cell recognition and overcome drug resistance using hyaluronic acid and α‑Tocopheryl succinate based multifunctional nanoparticles, Mol. Pharm. 2015, 12:2189−2202.
3、已授权相关专利:
[1] 钟海军,彭涛兴,郭锋,梁德胜,一种储存物理稳定性好的环孢素固体脂质纳米粒及其制备方法,CN108379238A,发明专利,中国,2018-08-10。
[2] 钟海军,彭涛兴,郭锋,梁德胜,一种烷基化菊糖衍生物作为乳化剂的固体脂质纳米粒及其制备方法,CN108295048A,发明专利,中国,2018-07-20。
[3] 钟海军,刘玲,郭锋,梁德胜,一种固体脂质纳米粒及其制备方法,CN107875395A,发明专利,中国,2018-04-06。
4、参编专业教材:
[1] 《药剂学》钟海军、李瑞 主编,华中科技大学出版社,ISBN 978-7-5680-7173-4
[2] 《药剂学实验》李瑞 主编,华中科技大学出版社,ISBN 978-7-5680-5839-1